Akihiko Saitoh

Summary

Affiliation: Niigata University
Country: Japan

Publications

  1. ncbi request reprint Recent progress and concerns regarding the Japanese immunization program: addressing the "vaccine gap"
    Akihiko Saitoh
    Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, 1 757 Asahimachi dori, Chuo Ku, Niigata 951 8510, Japan Pediatric Infectious Diseases, University of California, San Diego, 9500 Gilman Dr, MC 0672, La Jolla, CA 92093 0672, USA Electronic address
    Vaccine 32:4253-8. 2014
  2. doi request reprint The value of radiographic findings for the progression of pandemic 2009 influenza A/H1N1 virus infection
    Takanori Funaki
    Department of Medical Subspecialties, Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan
    BMC Infect Dis 13:516. 2013
  3. doi request reprint Safety and persistence of immunological response 6 months after intramuscular vaccination with an AS03-adjuvanted H1N1 2009 influenza vaccine: an open-label, randomized trial in Japanese children aged 6 months to 17 years
    Akihiko Saitoh
    Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
    Hum Vaccin Immunother 8:749-58. 2012
  4. doi request reprint Current issues with the immunization program in Japan: can we fill the "vaccine gap"?
    Akihiko Saitoh
    Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, 1 757 Asahimachi dori, Chuo Ku, Niigata 951 8510, Japan
    Vaccine 30:4752-6. 2012
  5. doi request reprint An infant with human parechovirus type 3 infection with a distinctive rash on the extremities
    Kensuke Shoji
    Division of Infectious Disease, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, JapanDivision of General Pediatrics, Department of Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan
    Pediatr Dermatol 31:258-9. 2014
  6. doi request reprint A universal preemptive therapy for cytomegalovirus infections in children after live-donor liver transplantation
    Akihiko Saitoh
    Division of Infectious Diseases, Department of Medical Specialties, National Center for Child Health and Development, Tokyo, Japan
    Transplantation 92:930-5. 2011
  7. doi request reprint Treatment of pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in children
    Tomohiro Katsuta
    Department of Pediatrics, Division of Infectious Diseases, St Marianna University School of Medicine, Kanagawa, Japan
    Pediatr Infect Dis J 32:417-9. 2013
  8. doi request reprint Complete atrioventricular block as a complication of varicella in children
    Tomohiro Katsuta
    Division of Infectious Diseases, Department of Medical Specialties, National Center for Child Health and Development, Tokyo, Japan
    Pediatr Infect Dis J 30:445-6. 2011
  9. doi request reprint Dermatologic manifestations of human parechovirus type 3 infection in neonates and infants
    Kensuke Shoji
    Department of Medical Subspecialties, Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan
    Pediatr Infect Dis J 32:233-6. 2013

Collaborators

  • Mureo Kasahara
  • Takanobu Shigeta
  • Seisuke Sakamoto
  • Akinari Fukuda
  • Kensuke Shoji
  • Tomohiro Katsuta
  • Takanori Funaki
  • Hisako Komuro
  • Ippei Miyata
  • Yoshinori Kobayashi
  • Tatsuhiko Shike
  • Isao Miyairi
  • Nobuyuki Yotani
  • Shunsuke Nosaka
  • Osamu Miyazaki
  • Yasushi Watanabe
  • Hidekazu Masaki
  • Hitoshi Kato
  • Masahide Kaneko
  • Yukihiro Kaneko
  • Yasushi Misaki
  • Mitsutoshi Kimura
  • Hiro Nakao

Detail Information

Publications9

  1. ncbi request reprint Recent progress and concerns regarding the Japanese immunization program: addressing the "vaccine gap"
    Akihiko Saitoh
    Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, 1 757 Asahimachi dori, Chuo Ku, Niigata 951 8510, Japan Pediatric Infectious Diseases, University of California, San Diego, 9500 Gilman Dr, MC 0672, La Jolla, CA 92093 0672, USA Electronic address
    Vaccine 32:4253-8. 2014
    ..We hope that future initiatives will further address the vaccine gap and protect Japanese children from vaccine-preventable diseases. ..
  2. doi request reprint The value of radiographic findings for the progression of pandemic 2009 influenza A/H1N1 virus infection
    Takanori Funaki
    Department of Medical Subspecialties, Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan
    BMC Infect Dis 13:516. 2013
    ..We investigated factors associated with rapid disease progression among children admitted to hospital for A/H1N1 infection, particularly findings on initial chest radiographs...
  3. doi request reprint Safety and persistence of immunological response 6 months after intramuscular vaccination with an AS03-adjuvanted H1N1 2009 influenza vaccine: an open-label, randomized trial in Japanese children aged 6 months to 17 years
    Akihiko Saitoh
    Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
    Hum Vaccin Immunother 8:749-58. 2012
    ..75 µg HA AS03-adjuvanted H1N1 2009 pandemic influenza vaccine in children aged 6 mo-17 y induced strong immune responses against the vaccine homologous strain that persisted for at least six months after the first vaccine dose...
  4. doi request reprint Current issues with the immunization program in Japan: can we fill the "vaccine gap"?
    Akihiko Saitoh
    Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, 1 757 Asahimachi dori, Chuo Ku, Niigata 951 8510, Japan
    Vaccine 30:4752-6. 2012
    ....
  5. doi request reprint An infant with human parechovirus type 3 infection with a distinctive rash on the extremities
    Kensuke Shoji
    Division of Infectious Disease, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, JapanDivision of General Pediatrics, Department of Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan
    Pediatr Dermatol 31:258-9. 2014
    ....
  6. doi request reprint A universal preemptive therapy for cytomegalovirus infections in children after live-donor liver transplantation
    Akihiko Saitoh
    Division of Infectious Diseases, Department of Medical Specialties, National Center for Child Health and Development, Tokyo, Japan
    Transplantation 92:930-5. 2011
    ..The current set of guidelines recommends prophylaxis over a preemptive therapy for pediatric LT; however, the data regarding the optimal approach after LT in children are limited...
  7. doi request reprint Treatment of pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in children
    Tomohiro Katsuta
    Department of Pediatrics, Division of Infectious Diseases, St Marianna University School of Medicine, Kanagawa, Japan
    Pediatr Infect Dis J 32:417-9. 2013
    ..Children with pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriaceae can be successfully treated with noncarbapenem antimicrobials...
  8. doi request reprint Complete atrioventricular block as a complication of varicella in children
    Tomohiro Katsuta
    Division of Infectious Diseases, Department of Medical Specialties, National Center for Child Health and Development, Tokyo, Japan
    Pediatr Infect Dis J 30:445-6. 2011
    ..Universal vaccination is warranted to prevent such a potentially fatal complication in Japan where varicella is still endemic...
  9. doi request reprint Dermatologic manifestations of human parechovirus type 3 infection in neonates and infants
    Kensuke Shoji
    Department of Medical Subspecialties, Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan
    Pediatr Infect Dis J 32:233-6. 2013
    ..Although maculopapular rash is a reported clinical manifestation of HPeV3 infection, the frequency and detailed characteristics of rash in neonates and young infants with HPeV3 infection are unknown...